Bone Marrow Aspirate Concentrate for Anterior Cruciate Ligament Tear Treatment.
ConditionAnterior Cruciate Ligament Tear
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-55
Sponsorabdulmajeed hammadi
About this trial
A single armed multicenter study enrolling 20 patients using autologous bone marrow aspirate concentrate (which is done under local or general anesthesia to aspirate around 1-2 cc/kg body weight then concentration which is done by using centrifugation and special disposable kit) local injection of 4 cc per joint under ultrasonic guidance ,completely sterile field with local anesthesia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Single group
Treatments tested in this trial
autologous bone marrow aspirate concentrate
Procedure/Surgerylocal knee joint injection of autologous bone marrow
Treatment groups
20 Participants
are divided into 1 treatment groupGroup A: bone marrow injectionExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Functional recovery by clinical assessments of the ACL and overall knee joint stability.
lachman test
Time frame
every 12 weeks till 6 monthsSecondary outcomes
1
magnetic resonance imaging of the knee joint
to assess the degree of anterior cruciate ligament tear
Time frame
6 months from starting recruitmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
abdulmajeed hammadi
Lead sponsor
Global Stem Cell Center, Baghdad
Sponsor institution
Source ClinicalTrials.gov